SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 209 filers reported holding SAGE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,842,478 | +66.5% | 47,050 | +37.4% | 0.02% | +66.7% |
Q2 2022 | $1,106,275 | +13.3% | 34,250 | +16.1% | 0.01% | +50.0% |
Q1 2022 | $976,450 | +33.4% | 29,500 | +71.5% | 0.01% | +50.0% |
Q4 2021 | $731,943 | +81.5% | 17,206 | +89.1% | 0.00% | +33.3% |
Q3 2021 | $403,221 | -91.7% | 9,100 | -89.3% | 0.00% | -90.3% |
Q2 2021 | $4,844,644 | -46.6% | 85,278 | -29.7% | 0.03% | -60.8% |
Q1 2021 | $9,079,305 | +22.9% | 121,300 | +42.0% | 0.08% | +38.6% |
Q4 2020 | $7,387,954 | +92.7% | 85,400 | +36.2% | 0.06% | +32.6% |
Q3 2020 | $3,833,000 | +163.4% | 62,700 | +79.1% | 0.04% | +152.9% |
Q2 2020 | $1,455,000 | +388.3% | 35,000 | +237.7% | 0.02% | +466.7% |
Q1 2020 | $298,000 | -97.8% | 10,365 | -94.6% | 0.00% | -97.2% |
Q4 2019 | $13,754,000 | -32.7% | 190,518 | +30.8% | 0.11% | -32.3% |
Q3 2019 | $20,430,000 | -24.9% | 145,624 | -2.0% | 0.16% | -20.2% |
Q2 2019 | $27,213,000 | +3.6% | 148,629 | -10.0% | 0.20% | -8.3% |
Q1 2019 | $26,275,000 | +264.5% | 165,200 | +119.5% | 0.22% | +266.1% |
Q4 2018 | $7,208,000 | +118.1% | 75,253 | +81.3% | 0.06% | +168.2% |
Q2 2017 | $3,305,000 | +287.5% | 41,500 | +245.8% | 0.02% | +266.7% |
Q1 2017 | $853,000 | -79.9% | 12,000 | -87.0% | 0.01% | -72.7% |
Q3 2016 | $4,247,000 | -83.4% | 92,226 | -89.2% | 0.02% | -81.2% |
Q2 2016 | $25,626,000 | +11601.4% | 850,510 | +28250.3% | 0.12% | +11600.0% |
Q2 2015 | $219,000 | – | 3,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
RA Capital Management | 455,173 | $74,972,000 | 6.27% |
Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |